Varian Receives FDA 510(k) Clearance for RapidArc

The FDA has granted 510(k) clearances for Varian Medical Systems’ RapidArc radiotherapy technology.

The technology will deliver image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than conventional IMRT or helical tomotherapy.

Studies comparing fixed-beam RapidArc with helical IMRT show that RapidArc can reduce the amount of nontherapeutic radiation reaching healthy tissues during treatment, according to Varian.